These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32649306)

  • 1. Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4.
    Espana B; Joseph-Tornabène F; Jaquet C; Perrot S; Prouillac C
    Int J Pharm Compd; 2020; 24(4):327-336. PubMed ID: 32649306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend SF PH4 oral suspensions.
    Polonini HC; Silva SL; Cunha CN; Brandão MA; Ferreira AO
    Pharmazie; 2016 Apr; 71(4):185-91. PubMed ID: 27209697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
    Geiger CM; Sorenson B; Whaley P
    Int J Pharm Compd; 2015; 19(5):420-7. PubMed ID: 26775449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4.
    Polonini H; da Silva SL; Cunha CN; Ferreira AO; Anagnostou K; Dijkers E
    Int J Pharm Compd; 2020; 24(3):252-262. PubMed ID: 32401746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: IJPC. 2020; 24(4): 327 Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF PH4.
    Int J Pharm Compd; 2020; 24(6):527. PubMed ID: 33217744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
    Polonini HC; Loures S; de Araujo EP; Brandão MA; Ferreira AO
    Int J Pharm Compd; 2016; 20(5):426-434. PubMed ID: 28339378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4.
    Ferreira AO; Polonini H; da Silva SL; Aglio NCB; Abreu J; Fernandes BMA
    Int J Pharm Compd; 2017; 21(4):339-346. PubMed ID: 28719377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4.
    Polonini H; da Silva SL; Brandão MAF; Bauters T; De Moerloose B; Ferreira AO
    Int J Pharm Compd; 2018; 22(6):516-526. PubMed ID: 30384353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt.
    Graves RA; Mandal TK; Bostanian LA; Nguyen AT; Swopes D; Morris TC; Pramar YV
    Int J Pharm Compd; 2019; 23(6):519-527. PubMed ID: 31751949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions.
    Ferreira AO; Polonini HC; Loures da Silva S; Cerqueira de Melo VA; de Andrade L; Brandão MAF
    Int J Pharm Compd; 2017; 21(3):255-263. PubMed ID: 28557789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF.
    Friciu M; Cull E; Leclair G
    Int J Pharm Compd; 2024; 28(5):408-412. PubMed ID: 39405569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of midazolam in syrspend SF and syrspend SF cherry.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(4):344-6. PubMed ID: 24261150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions.
    Polonini HC; Loures S; Lima LC; Ferreira AO; Brandão MA
    Int J Pharm Compd; 2016; 20(2):167-74. PubMed ID: 27323429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend(®) SF PH4 oral suspensions.
    Ferreira AO; Polonini HC; Silva SL; Patrício FB; Brandão MAF; Raposo NRB
    J Pharm Biomed Anal; 2016 Jan; 118():105-112. PubMed ID: 26540625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline concentration over time after storage in a compounded veterinary preparation.
    Papich MG; Davidson GS; Fortier LA
    J Am Vet Med Assoc; 2013 Jun; 242(12):1674-8. PubMed ID: 23725430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
    Zhao F; Dave VS; Mar MZ; Perri JR
    Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of acetazolamide in suspension compounded from tablets.
    Alexander KS; Haribhakti RP; Parker GA
    Am J Hosp Pharm; 1991 Jun; 48(6):1241-4. PubMed ID: 1858804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Le G; Morris TC; Graves RA
    Int J Pharm Compd; 2020; 24(5):413-419. PubMed ID: 32886640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of an extemporaneous oral liquid aprepitant formulation.
    Dupuis LL; Lingertat-Walsh K; Walker SE
    Support Care Cancer; 2009 Jun; 17(6):701-6. PubMed ID: 19043742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.